EUVIMEDEUVIMED entdecken
Crossref

Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients

Cem Onal iD, Aysenur Elmali iD, Gurcan Erbay, Birhan Demirhan iD, Philip Sutera, Matthew P Deek, Phuoc T Tran, Ozan Cem Guler

The Prostate · 2025

DOI: 10.1002/pros.24833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, 2025. Verfasst von Cem Onal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Baskent University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Diffusion Magnetic Resonance Imaging. Die Arbeit nennt 33 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate the utility of diffusion‐weighted magnetic resonance imaging (DW‐MRI) in evaluating Gleason score (GS) 7 tumors before definitive radiotherapy (RT) and to explore its association with clinicopathological factors and treatment outcomes. Materials and Methods Clinical data of 266 prostate cancer (PCa) patients with biopsy‐confirmed GS 7 who underwent RT were retrospectively analyzed. Pretreatment DW‐MRI was utilized to measure apparent diffusion coefficient (ADC) values of primary tumors. Treatment outcomes, including biochemical disease‐free survival (bDFS) and prostate cancer‐specific survival (PCSS), were assessed. Statistical analyses were conducted to determine the correlation between tumor ADC values, clinicopathological factors, and treatment outcomes.

Results

Tumors with a GS of 3 + 4 had significantly higher ADC values than those with a GS of 4 + 3 (0.746 ± 0.150 vs. 0.702 ± 0.157 × 10 − ³ mm²/s; p < 0.001). Median follow‐up time was 8.6 years, and the 7‐year rates for bDFS and PCSS were 89.1% and 95.3%, respectively. Lower tumor ADC values were significantly correlated with higher GS and increased risk of disease progression. A primary tumor ADC cutoff value of 0.682 × 10 − ³ mm²/s was identified for predicting disease progression. Patients with higher ADC values exhibited significantly better 7‐year bDFS rates (92.8% vs. 83.2%; p = 0.02). However, GS 4 + 3 tumors independently predicted poorer bDFS and PCSS outcomes. In the multivariable analysis, only GS 4 + 3 tumor was predictive for worse bDFS and PCSS.

Conclusions

Tumor ADC values are a reliable biomarker for differentiating between GS 3 + 4 and 4 + 3 tumors in the GS 7 category. Tumors exhibiting lower ADC values have been associated to higher risk factors and an increased likelihood of disease progression, particularly in GS 3 + 4 tumors where GS upgrading could happen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsDiffusion Magnetic Resonance ImagingHumansMaleNeoplasm GradingAgedMiddle AgedRetrospective StudiesPrognosisTreatment OutcomeDisease-Free Survival

Stichwörter der Autor:innen

Gleason scoreapparent diffusion coefficientdiffusion weighted imagemagnetic resonance imagingradiotherapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Baskent University Faculty of Medicine, Ankara, Turkey.
  • Department of Radiation Oncology, Baskent University Faculty of Medicine Adana Dr. Turgut Noyan Research and Treatment Center, Adana, Turkey.
  • Department of Radiology, Baskent University Faculty of Medicine Adana Dr. Turgut Noyan Research and Treatment Center, Adana, Turkey.
  • Division of Radiation Oncology, Iskenderun Gelisim Hospital, Hatay, Turkey.
  • Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.

ORCID-Profile: Cem Onal, Aysenur Elmali, Birhan Demirhan

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Onal, C., Elmali, A., Erbay, G., Demirhan, B., Sutera, P., Deek, M. P., Tran, P. T., & Guler, O. C. (2025). Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients. The Prostate. https://doi.org/10.1002/pros.24833

Vancouver

Onal C, Elmali A, Erbay G, Demirhan B, Sutera P, Deek MP, et al. Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients. The Prostate. 2025. doi:10.1002/pros.24833

BibTeX
@article{Onal2025,
  author = {Onal, Cem and Elmali, Aysenur and Erbay, Gurcan and Demirhan, Birhan and Sutera, Philip and Deek, Matthew P and Tran, Phuoc T and Guler, Ozan Cem},
  title = {Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients},
  journal = {The Prostate},
  year = {2025},
  doi = {10.1002/pros.24833}
}
Kostenlos starten →